BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21253487)

  • 1. Molecular characterization of putative chordoma cell lines.
    Brüderlein S; Sommer JB; Meltzer PS; Li S; Osada T; Ng D; Möller P; Alcorta DA; Kelley MJ
    Sarcoma; 2010; 2010():630129. PubMed ID: 21253487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and characterization of a chordoma cell line from the tissue of a patient with dedifferentiated-type chordoma.
    Kim JY; Lee J; Koh JS; Park MJ; Chang UK
    J Neurosurg Spine; 2016 Nov; 25(5):626-635. PubMed ID: 27314550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chordoma-derived cell line U-CH1-N recapitulates the biological properties of notochordal nucleus pulposus cells.
    Fujita N; Suzuki S; Watanabe K; Ishii K; Watanabe R; Shimoda M; Takubo K; Tsuji T; Toyama Y; Miyamoto T; Horiuchi K; Nakamura M; Matsumoto M
    J Orthop Res; 2016 Aug; 34(8):1341-50. PubMed ID: 27248133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment and genomic characterization of the new chordoma cell line Chor-IN-1.
    Bosotti R; Magnaghi P; Di Bella S; Cozzi L; Cusi C; Bozzi F; Beltrami N; Carapezza G; Ballinari D; Amboldi N; Lupi R; Somaschini A; Raddrizzani L; Salom B; Galvani A; Stacchiotti S; Tamborini E; Isacchi A
    Sci Rep; 2017 Aug; 7(1):9226. PubMed ID: 28835717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro characterization of cells derived from chordoma cell line U-CH1 following treatment with X-rays, heavy ions and chemotherapeutic drugs.
    Kato TA; Tsuda A; Uesaka M; Fujimori A; Kamada T; Tsujii H; Okayasu R
    Radiat Oncol; 2011 Sep; 6():116. PubMed ID: 21914223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, U-CH1.
    Scheil S; Brüderlein S; Liehr T; Starke H; Herms J; Schulte M; Möller P
    Genes Chromosomes Cancer; 2001 Nov; 32(3):203-11. PubMed ID: 11579460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. U-CH17P, -M and -S, a new cell culture system for tumor diversity and progression in chordoma.
    Jäger D; Lechel A; Tharehalli U; Seeling C; Möller P; Barth TFE; Mellert K
    Int J Cancer; 2018 Apr; 142(7):1369-1378. PubMed ID: 29148152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of repurposed small molecule drugs for chordoma therapy.
    Xia M; Huang R; Sakamuru S; Alcorta D; Cho MH; Lee DH; Park DM; Kelley MJ; Sommer J; Austin CP
    Cancer Biol Ther; 2013 Jul; 14(7):638-47. PubMed ID: 23792643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brachyury gene copy number gain and activation of the PI3K/Akt pathway: association with upregulation of oncogenic Brachyury expression in skull base chordoma.
    Otani R; Mukasa A; Shin M; Omata M; Takayanagi S; Tanaka S; Ueki K; Saito N
    J Neurosurg; 2018 May; 128(5):1428-1437. PubMed ID: 28753115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and analysis of human chordoma cell lines.
    Yang C; Hornicek FJ; Wood KB; Schwab JH; Choy E; Iafrate J; Rosenberg A; Nielsen GP; Xavier RJ; Mankin H; Duan Z
    Spine (Phila Pa 1976); 2010 Jun; 35(13):1257-64. PubMed ID: 20461036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study.
    Presneau N; Shalaby A; Ye H; Pillay N; Halai D; Idowu B; Tirabosco R; Whitwell D; Jacques TS; Kindblom LG; Brüderlein S; Möller P; Leithner A; Liegl B; Amary FM; Athanasou NN; Hogendoorn PC; Mertens F; Szuhai K; Flanagan AM
    J Pathol; 2011 Feb; 223(3):327-35. PubMed ID: 21171078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and Brachyury.
    Magnaghi P; Salom B; Cozzi L; Amboldi N; Ballinari D; Tamborini E; Gasparri F; Montagnoli A; Raddrizzani L; Somaschini A; Bosotti R; Orrenius C; Bozzi F; Pilotti S; Galvani A; Sommer J; Stacchiotti S; Isacchi A
    Mol Cancer Ther; 2018 Mar; 17(3):603-613. PubMed ID: 29237806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential function of microRNA in chordomas.
    Gulluoglu S; Tuysuz EC; Kuskucu A; Ture U; Atalay B; Sahin F; Bayrak OF
    Gene; 2016 Jul; 585(1):76-83. PubMed ID: 27016303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the Cohesive Cluster Phenotype in Chordoma via β1 Integrin Increases Ionizing Radiation Efficacy.
    Harryman WL; Gard JMC; Pond KW; Simpson SJ; Heppner LH; Hernandez-Cortes D; Little AS; Eschbacher JM; Cress AE
    Neoplasia; 2017 Nov; 19(11):919-927. PubMed ID: 28954241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel therapeutic targets in chordoma.
    Bydon M; Papadimitriou K; Witham T; Wolinsky JP; Bydon A; Sciubba D; Gokaslan Z
    Expert Opin Ther Targets; 2012 Nov; 16(11):1139-43. PubMed ID: 22860993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical Characterization of Novel Chordoma Cell Systems and Their Targeting by Pharmocological Inhibitors of the CDK4/6 Cell-Cycle Pathway.
    von Witzleben A; Goerttler LT; Marienfeld R; Barth H; Lechel A; Mellert K; Böhm M; Kornmann M; Mayer-Steinacker R; von Baer A; Schultheiss M; Flanagan AM; Möller P; Brüderlein S; Barth TF
    Cancer Res; 2015 Sep; 75(18):3823-31. PubMed ID: 26183925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment and characterization of a novel chordoma cell line: CH22.
    Liu X; Nielsen GP; Rosenberg AE; Waterman PR; Yang W; Choy E; Sassi S; Yang S; Harmon DC; Yang C; Schwab JH; Kobayashi E; Mankin HJ; Xavier R; Weissleder R; Duan Z; Hornicek FJ
    J Orthop Res; 2012 Oct; 30(10):1666-73. PubMed ID: 22504929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic aberrations frequently alter chromatin regulatory genes in chordoma.
    Wang L; Zehir A; Nafa K; Zhou N; Berger MF; Casanova J; Sadowska J; Lu C; Allis CD; Gounder M; Chandhanayingyong C; Ladanyi M; Boland PJ; Hameed M
    Genes Chromosomes Cancer; 2016 Jul; 55(7):591-600. PubMed ID: 27072194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioresistance of chordoma cells is associated with the ATM/ATR pathway, in which RAD51 serves as an important downstream effector.
    Zhang C; Wang B; Li L; Li Y; Li P; Lv G
    Exp Ther Med; 2017 Sep; 14(3):2171-2179. PubMed ID: 28962138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciprofloxacin enhances phototoxicity of 5-aminolevulinic acid mediated photodynamic treatment for chordoma cell lines.
    Gull HH; Karadag C; Senger B; Sorg RV; Möller P; Mellert K; Steiger HJ; Hänggi D; Cornelius JF
    Photodiagnosis Photodyn Ther; 2021 Sep; 35():102346. PubMed ID: 34038764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.